SILVERIO, ANGELO
 Distribuzione geografica
Continente #
AS - Asia 5.007
NA - Nord America 2.797
EU - Europa 1.313
SA - Sud America 323
AF - Africa 63
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.511
Nazione #
HK - Hong Kong 3.304
US - Stati Uniti d'America 2.716
SG - Singapore 787
IT - Italia 534
CN - Cina 295
VN - Vietnam 274
BR - Brasile 250
RU - Federazione Russa 213
DE - Germania 169
FR - Francia 82
FI - Finlandia 60
IN - India 57
BD - Bangladesh 55
IE - Irlanda 47
CA - Canada 39
TR - Turchia 39
KR - Corea 38
UA - Ucraina 37
GB - Regno Unito 36
SE - Svezia 27
MX - Messico 26
NL - Olanda 26
JP - Giappone 25
AR - Argentina 23
PL - Polonia 21
ID - Indonesia 20
ES - Italia 19
IQ - Iraq 19
ZA - Sudafrica 18
CO - Colombia 16
CZ - Repubblica Ceca 13
EC - Ecuador 13
SA - Arabia Saudita 13
PK - Pakistan 11
MA - Marocco 10
PH - Filippine 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
CL - Cile 8
KE - Kenya 8
MY - Malesia 8
LU - Lussemburgo 7
EG - Egitto 6
LT - Lituania 6
VE - Venezuela 6
KZ - Kazakistan 5
NP - Nepal 5
DZ - Algeria 4
LB - Libano 4
PS - Palestinian Territory 4
RO - Romania 4
AL - Albania 3
AU - Australia 3
EU - Europa 3
JM - Giamaica 3
JO - Giordania 3
PA - Panama 3
TN - Tunisia 3
AT - Austria 2
AZ - Azerbaigian 2
BH - Bahrain 2
HU - Ungheria 2
IL - Israele 2
KW - Kuwait 2
LY - Libia 2
PY - Paraguay 2
SN - Senegal 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AO - Angola 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BZ - Belize 1
CG - Congo 1
CH - Svizzera 1
CM - Camerun 1
CR - Costa Rica 1
CV - Capo Verde 1
CY - Cipro 1
ET - Etiopia 1
FJ - Figi 1
GD - Grenada 1
GF - Guiana Francese 1
GP - Guadalupe 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
LV - Lettonia 1
NE - Niger 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SO - Somalia 1
SV - El Salvador 1
Totale 9.507
Città #
Hong Kong 3.301
Singapore 428
San Jose 407
Ashburn 257
Milan 218
Ann Arbor 201
Dallas 195
Chandler 180
Munich 101
Princeton 101
Wilmington 94
Council Bluffs 85
Ho Chi Minh City 84
Beijing 78
Los Angeles 73
Houston 72
Lauterbourg 69
Rome 65
Woodbridge 54
Hanoi 53
New York 51
The Dalles 49
Boardman 48
Jacksonville 48
Dublin 45
Turku 44
Dong Ket 43
Santa Clara 41
São Paulo 29
Moscow 27
Memphis 25
Denver 22
Izmir 22
Montreal 21
Tokyo 21
Turin 20
Frankfurt am Main 19
Naples 19
Salerno 18
Warsaw 18
Andover 17
Orem 17
Amsterdam 15
Mestre 15
Phoenix 15
Washington 15
Nanjing 14
Chicago 13
Mexico City 13
Chennai 12
Johannesburg 12
Brno 11
Da Nang 11
Falls Church 11
Atlanta 10
Haiphong 10
Stockholm 10
Brooklyn 9
Nuremberg 9
Poplar 9
Rio de Janeiro 9
Seattle 9
Tashkent 9
Belo Horizonte 8
Boston 8
Pellezzano 8
Toronto 8
Brasília 7
Columbus 7
Fairfield 7
Figino 7
Helsinki 7
Querétaro 7
San Francisco 7
Würselen 7
Ankara 6
Buffalo 6
Cairo 6
Manchester 6
Nairobi 6
New Delhi 6
Seoul 6
Baghdad 5
Bologna 5
Dammam 5
Dudelange 5
Florence 5
Guayaquil 5
London 5
Mumbai 5
Nanchang 5
Norwalk 5
Palermo 5
Paris 5
Redwood City 5
Bari 4
Campinas 4
Changsha 4
Charlotte 4
City of London 4
Totale 7.236
Nome #
Clinical Characteristics and Outcomes of Patients With Takotsubo Syndrome and Left Ventricular Outflow Tract Obstruction 938
Moving toward Precision Medicine in Acute Coronary Syndromes: A Multimodal Assessment of Non-Culprit Lesions 529
Predictors of Recurrent Ischemic Events in Patients With ST-Segment Elevation Myocardial Infarction 433
Infective endocarditis and diabetes mellitus: Results from a single-center study from 1994 to 2017 390
A novel MIR-371a-5p-mediated pathway, leading to BAG3 upregulation in cardiomyocytes in response to epinephrine, is lost in Takotsubo cardiomyopathy 327
COVID-19 and Acute Coronary Syndromes: From Pathophysiology to Clinical Perspectives 294
Importance of Echocardiography and Clinical "Red Flags" in Guiding Genetic Screening for Fabry Disease 246
Anterior mitral valve aneurysm perforation in a patient with preexisting aortic regurgitation 226
Polymorphisms of the antiapoptotic protein bag3 may play a role in the pathogenesis of tako-tsubo cardiomyopathy 196
Clinical outcome of patients with ST-elevation myocardial infarction and angiographic evidence of coronary artery ectasia 188
Partial clip detachment and posterior mitral leaflet perforation after mitraclip implantation 169
Global longitudinal strain predicts outcome after MitraClip implantation for secondary mitral regurgitation 165
Aortic dissection in patients with autosomal dominant polycystic kidney disease: a series of two cases and a review of the literature 162
Clinical profile and in-hospital outcome of Caucasian patients with takotsubo syndrome and right ventricular involvement 160
Arterial Hypertension in Patients with Takotsubo Syndrome: Prevalence, Long-Term Outcome, and Secondary Preventive Strategies. A Report from the Takotsubo Italian Network Register 155
Valve-in-Valve Transcatheter Aortic Valve Replacement: From Pre-Procedural Planning to Procedural Scenarios and Possible Complications 154
Predictors of outcome in heart failure patients with severe functional mitral regurgitation undergoing MitraClip treatment 149
Thrombus straddling a patent foramen ovale 148
Role of multimodality imaging in evaluation of cardiovascular involvement in COVID-19 136
Contemporary imaging in takotsubo syndrome 135
Safety and efficacy of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation 130
Secondary Cardiovascular Prevention after Acute Coronary Syndrome: Emerging Risk Factors and Novel Therapeutic Targets 129
Intravenous antiplatelet therapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention 121
Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction 119
Beta-blockers are associated with better long-term survival in patients with Takotsubo syndrome 117
Prognostic significance of the SYNTAX score and SYNTAX score II in patients with myocardial infarction treated with percutaneous coronary intervention 112
Clinical conditions and echocardiographic parameters associated with mortality in COVID-19 111
Transcatheter repair of functional mitral regurgitation in heart failure patients: A meta-analysis of 23 studies on mitraclip implantation 108
Lipoprotein(a) levels and risk of adverse events after myocardial infarction in patients with and without diabetes 107
Risk stratification using the CHA2DS2-VASc score in Takotsubo syndrome: Data from the Takotsubo Italian network 106
Prognostic Implications of Right Ventricular Function and Pulmonary Pressures Assessed by Echocardiography in Hospitalized Patients with COVID-19 106
Long-term outcome in patients with Takotsubo syndrome presenting with severely reduced left ventricular ejection fraction 105
From Planning to Practice: Impact of Achieved Proximal Sealing Zone in Endovascular Aneurysm Repair (EVAR) 104
Prevalence and Predictors of Out-of-Target LDL Cholesterol 1 to 3 Years After Myocardial Infarction. A Subanalysis From the EYESHOT Post-MI Registry 102
Safety and feasibility of balloon aortic valvuloplasty in non-TAVI centers: The “BAV for life” experience 100
Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients 98
Big Health Data and Cardiovascular Diseases: A Challenge for Research, an Opportunity for Clinical Care 97
Anti-Apoptotic BAG3 Gene in Tako-Tsubo Cardiomyopathy 96
A peculiar etiology of acute heart failure: adrenergic myocarditis 93
Meta-Analysis Comparing Outcomes After Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients with Acute Coronary Syndromes 92
Cardiovascular Involvement in COVID-19: What Sequelae Should We Expect? 91
Machine learning-based prediction of in-hospital death for patients with takotsubo syndrome: The InterTAK-ML model 87
Reply 86
Biomarkers predict in-hospital major adverse cardiac events in covid-19 patients: A multicenter international study 85
Angiographic and clinical outcome of SARS-CoV-2 positive patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: A collaborative, individual patient data meta-analysis of six registry-based studies 84
Artificial intelligence in cardiovascular prevention: new ways will open new doors 83
Novel targets and strategies addressing residual cardiovascular risk in post-acute coronary syndromes patients 81
Clinical and Echocardiographic Features of Patients With Infective Endocarditis and Bicuspid Aortic Valve According to Echocardiographic Definition of Valve Morphology 79
Predictors of outcome in patients with de novo diagnosis of heart failure with reduced ejection fraction: Role of combined myocardial and lung Iodine-123 Meta-Iodobenzylguanidine imaging 77
Balloon aortic valvuloplasty for urgent treatment of severe aortic stenosis during coronavirus disease 2019 pandemic: a case report 75
Soluble PCSK9 Inhibition: Indications, Clinical Impact, New Molecular Insights and Practical Approach-Where Do We Stand? 70
Current Use of Oral Anticoagulation Therapy in Elderly Patients with Atrial Fibrillation: Results from an Italian Multicenter Prospective Study-The ISNEP Study 70
Prognostic Impact of Mitral Regurgitation Before and After Transcatheter Aortic Valve Replacement in Patients With Severe Low-Flow, Low-Gradient Aortic Stenosis 69
How the COAPT trial affected the selection of patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair: insights from the GIOTTO registry 68
Impella in Takotsubo syndrome complicated by left ventricular outflow tract obstruction and severe mitral regurgitation 68
Dynamic Left Intraventricular Obstruction Phenotype in Takotsubo Syndrome 67
ICARUS score for predicting peri-procedural bleeding in patients undergoing percutaneous coronary intervention with cangrelor 62
Treatment and Outcome of Patients With Coronary Artery Ectasia: Current Evidence and Novel Opportunities for an Old Dilemma 61
Pulmonary embolism in COVID-19 patients: Prevalence, predictors and clinical outcome 59
Cardiovascular Mortality in Takotsubo Syndrome 56
Editorial: Advances in Percutaneous Coronary Intervention 53
Predictors of sacubitril/valsartan high dose tolerability in a real world population with HFrEF 52
Prevalence and Prognostic Significance of Right Ventricular Dysfunction in Patients With Severe Low‐Flow, Low‐Gradient Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement 52
Comparison of mortality in primary and secondary Takotsubo cardiomyopathy with severe left ventricular dysfunction: reply 49
Invasive and Non-invasive Assessment of Non-culprit Coronary Lesions in Patients with ST-segment Elevation Myocardial Infarction 47
Response to: Correspondence on 'Beta-blockers are associated with better long-term survival in patients with Takotsubo syndrome' by John E Madias 46
Chronic Oral Anticoagulation and Clinical Outcome in Hospitalized COVID-19 Patients 46
Response to: Correspondence on 'Beta-blockers are associated with better long-term survival in patients with Takotsubo syndrome' by Chang et al 43
null 40
Competing Risks of Cardiac and Noncardiac Mortality in Patients With Secondary Mitral Regurgitation Undergoing Transcatheter Edge‐to‐Edge Repair 38
Echocardiographic tools for prognostic stratification in transthyretin cardiac amyloidosis: a new arrow in the quiver 37
Consolidating the value of fondaparinux for current treatment of non-ST-elevation acute coronary syndromes 34
Clinical Outcome of Hospitalized COVID-19 Patients with History of Atrial Fibrillation 32
Loeffler’s Endocarditis: An Integrated Multimodality Approach 32
Predictors of thromboembolic events in Takotsubo syndrome: reply 32
Dual Antiplatelet Therapy with 3rd Generation P2Y12 Inhibitors in STEMI Patients: Impact of Body Mass Index on Loading Dose–Response 31
Validation of the academic research consortium high bleeding risk criteria in patients undergoing percutaneous coronary intervention: A systematic review and meta-analysis of 10 studies and 67,862 patients 27
Understanding changes in central nervous system function after transcatheter aortic valve replacement 21
Totale 9.643
Categoria #
all - tutte 27.959
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.959


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022184 0 0 0 2 11 8 6 13 24 18 25 77
2022/2023413 29 50 17 48 71 72 2 32 65 5 16 6
2023/2024353 11 36 35 14 33 67 6 9 0 17 13 112
2024/2025984 24 4 30 34 23 73 199 42 130 79 196 150
2025/20266.877 977 1.476 1.365 330 620 191 544 141 276 425 140 392
2026/202740 40 0 0 0 0 0 0 0 0 0 0 0
Totale 9.643